tiprankstipranks
JPMorgan Chase Ends Major Stake in Alterity Therapeutics
Company Announcements

JPMorgan Chase Ends Major Stake in Alterity Therapeutics

Alterity Therapeutics Ltd. (AU:ATH) has released an update.

JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in Alterity Therapeutics Ltd., with changes in their holdings including securities lending agreements, rehypothecation, and principal sales and purchases. The financial activities leading to this status change were completed by May 3, 2024, ending a significant investment relationship that began before March 2024.

For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TipRanks Australian Auto-Generated NewsdeskAlterity Therapeutics Seeks ASX Quotation
TipRanks Australian Auto-Generated NewsdeskAlterity Therapeutics Plans New Share Issue
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!